Competing in the Generic Drug Market: Strategies for Success

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

The generic drug market is a highly competitive and dynamic industry, with both opportunities and challenges. To succeed, generic drug manufacturers must adopt innovative strategies to differentiate themselves and stay ahead of the competition. Here are some key strategies for success in the generic drug market:

Develop Higher-Value Generics

One strategy is to focus on developing higher-value generics that offer improved efficacy, safety, or convenience compared to traditional generics. This can be achieved through innovative formulations, delivery systems, or manufacturing processes. By investing in research and development, generic manufacturers can create differentiated products that command a premium price and attract more customers.

Anticipate and Prepare for Patent Expiries

Another strategy is to anticipate and prepare for patent expiries. Generic manufacturers should closely monitor patent expiration dates and develop strategies to quickly enter the market with a generic version of the drug. This can involve filing Abbreviated New Drug Applications (ANDAs) with the FDA, conducting bioequivalence studies, and establishing manufacturing and distribution networks.

Combat Brand-Name Strategies

Brand-name pharmaceutical companies often employ strategies to delay generic market entry, such as obtaining additional patents, engaging in reverse-payment settlements, and restricting access to drug samples. Generic manufacturers must be aware of these tactics and develop counter-strategies to overcome them. This can involve challenging weak patents, negotiating with brand-name companies, and seeking regulatory support.

Incentivize Generic Uptake

Governments and regulatory agencies can play a crucial role in incentivizing generic uptake by promoting a favorable regulatory environment, encouraging competition, and ensuring timely FDA approvals. This can lead to lower drug prices, improved access to medicines, and significant cost savings for healthcare systems.

Employ Effective Marketing Strategies

Effective marketing strategies are essential for generic manufacturers to differentiate themselves and attract customers. This can involve creating brand equity, driving patient acquisition and retention, and leveraging copay cards and enrollment programs to maintain sales volume and reduce profit erosion.

Create Over-the-Counter Formulations

Some generic manufacturers may choose to create over-the-counter (OTC) formulations of their branded products to maintain and/or grow volume post-patent expiry. This strategy can help decelerate value erosion, maintain current customers, and acquire new ones.

Launch a Generic Version

Branded drug companies can also profit directly from patients who migrate to a generic alternative by offering a generic version of their branded drug. This strategy can allow the branded company to retain a higher portion of product value with relatively low implementation costs.

Collaborate and Partner

Finally, generic manufacturers can benefit from collaborating and partnering with other companies, regulatory agencies, and healthcare organizations. This can involve joint research and development, manufacturing and distribution agreements, and strategic partnerships to expand market reach and improve competitiveness.

Pullquote: “By developing higher-value generics, anticipating and preparing for patent expiries, combating brand-name strategies, incentivizing generic uptake, employing effective marketing strategies, creating OTC formulations, launching a generic version, and collaborating and partnering, generic drug manufacturers can succeed in this highly competitive market.”

References:

  1. KPMG. (2023). Generics 2030: Three strategies to curb the downward spiral. Retrieved from https://kpmg.com/us/en/articles/2023/generics-2030-curb-downward-spiral.html
  2. Commonwealth Fund. (2017). Strategies That Delay Market Entry of Generic Drugs. Retrieved from https://www.commonwealthfund.org/publications/journal-article/2017/sep/strategies-delay-market-entry-generic-drugs
  3. ASPE. (n.d.). Incentivizing Generic and Biosimilar Product Uptake. Retrieved from https://aspe.hhs.gov/topics/prescription-drugs-other-medical-products/prescription-drugs-0/incentivizing-generic-biosimilar-product-uptake
  4. Drug Topics. (2004). Big Pharma uses effective strategies to battle generic competitors. Retrieved from https://www.drugtopics.com/view/big-pharma-uses-effective-strategies-battle-generic-competitors
  5. Pharm Exec. (2016). Loss of Exclusivity: Strategies to Maximize Product Value. Retrieved from https://www.pharmexec.com/view/loss-exclusivity-strategies-maximize-product-value

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions